Rimonabant Redux and Strategies to Improve the Future Outlook of CB1 Receptor Neutral-Antagonist/Inverse-Agonist Therapies

Saved in:
Bibliographic Details
Published in:Obesity (Silver Spring, Md.) Md.), 2011-07, Vol.19 (7), p.1325-1334
Main Authors: Ward, Sara Jane, Raffa, Robert B.
Format: Article
Language:English
Subjects:
Animals
Appetite Depressants - adverse effects
Appetite Depressants - therapeutic use
Cannabinoid Receptor Modulators - antagonists & inhibitors
Dexfenfluramine - adverse effects
Dexfenfluramine - therapeutic use
Drug Design
Drug Inverse Agonism
Humans
Obesity - drug therapy
Piperidines - adverse effects
Piperidines - therapeutic use
Pyrazoles - adverse effects
Pyrazoles - therapeutic use
Receptor, Cannabinoid, CB1 - antagonists & inhibitors
Serotonin Receptor Agonists - adverse effects
Serotonin Receptor Agonists - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1930-7381
1930-739X
DOI:10.1038/oby.2011.69